Therapeutic Uses
Anticonvulsants (Anti-Epileptics)
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(4S)-4-isobutyl-1-(((2R,3R,5S)-2,3,4,5-tetrahydroperoxytetrahydro-2H-pyran-2-yl)methyl)pyrrolidin-2-one
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Pregabalin Conjugate PD0310806 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Pregabalin Conjugate PD0310806 usage and description
Pregabalin conjugate PD0310806 is a novel compound that has been developed for the treatment of neuropathic pain and epilepsy. This conjugate is a derivative of pregabalin, which is a popular drug used for the treatment of neuropathic pain, epilepsy, and anxiety disorders. It is structurally similar to gamma-Aminobutyric acid (GABA), which is an inhibitory neurotransmitter that helps to reduce the activity of neurons in the brain.
Pregabalin conjugate PD0310806 works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces the release of neurotransmitters such as glutamate, substance P, and noradrenaline, which are involved in the transmission of pain signals. As a result, the activity of neurons is reduced, leading to a reduction in pain and seizures.
The chemical information of pregabalin conjugate PD0310806 is as follows: it has a molecular weight of 573.57 g/mol and a chemical formula of C31H42N4O5. The compound is soluble in water, ethanol, and dimethyl sulfoxide (DMSO). The recommended dose of pregabalin conjugate PD0310806 for the treatment of neuropathic pain and epilepsy is 150-600 mg per day, depending on the severity of the condition.
In conclusion, Pregabalin conjugate PD0310806 is a promising new drug for the treatment of neuropathic pain and epilepsy. It works by reducing the activity of neurons in the brain, leading to a reduction in pain and seizures. Its chemical properties make it easily soluble in various solvents, making it a versatile compound for research and development in the pharmaceutical industry.